These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 22556403)

  • 61. [Dosimetry analysis of intensity-modulated and conformal radiation therapy for head and neck tumors].
    Pesznyák C; Béla D; Takácsi-Nagy Z; Major T; Polgár C
    Magy Onkol; 2015 Jun; 59(2):95-101. PubMed ID: 26035156
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Beam intensity modulation using tissue compensators or dynamic multileaf collimation in three-dimensional conformal radiotherapy of primary cancers of the oropharynx and larynx, including the elective neck.
    van Dieren EB; Nowak PJ; Wijers OB; van Sörnsen de Koste JR; van der Est H; Binnekamp DP; Heijmen BJ; Levendag PC
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1299-309. PubMed ID: 10889384
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical delivery of intensity modulated conformal radiotherapy for relapsed or second-primary head and neck cancer using a multileaf collimator with dynamic control.
    De Neve W; De Gersem W; Derycke S; De Meerleer G; Moerman M; Bate MT; Van Duyse B; Vakaet L; De Deene Y; Mersseman B; De Wagter C
    Radiother Oncol; 1999 Mar; 50(3):301-14. PubMed ID: 10392816
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation of unified intensity-modulated arc therapy for the radiotherapy of head-and-neck cancer.
    MacFarlane M; Hoover DA; Wong E; Read N; Palma D; Venkatesan V; Hammond A; Battista JJ; Chen JZ
    Radiother Oncol; 2016 May; 119(2):331-6. PubMed ID: 27041142
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparison of IMRT techniques in the radiotherapeutic management of head and neck cancer: is tomotherapy "better" than step-and-shoot IMRT?
    Chen AM; Marsano J; Perks J; Farwell G; Luu Q; Donald PJ; Purdy JA
    Technol Cancer Res Treat; 2011 Apr; 10(2):171-7. PubMed ID: 21381795
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Living with the Elekta Compact: Limitations and ways around them.
    Goswami J; Mallik S; Adhikary A; Das S; Pal B
    J Cancer Res Ther; 2015; 11(2):479-81. PubMed ID: 26148623
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Data-driven approach to generating achievable dose-volume histogram objectives in intensity-modulated radiotherapy planning.
    Wu B; Ricchetti F; Sanguineti G; Kazhdan M; Simari P; Jacques R; Taylor R; McNutt T
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1241-7. PubMed ID: 20800382
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Intensity-modulated radiation therapy for head and neck cancer in India: a promise waiting to be delivered.
    Anand AK
    J Cancer Res Ther; 2008; 4(4):148-50. PubMed ID: 19052385
    [No Abstract]   [Full Text] [Related]  

  • 69. Parotid gland sparing with helical tomotherapy in head-and-neck cancer.
    Voordeckers M; Farrag A; Everaert H; Tournel K; Storme G; Verellen D; De Ridder M
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):443-8. PubMed ID: 22836056
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre Phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancer.
    Clark CH; Miles EA; Urbano MT; Bhide SA; Bidmead AM; Harrington KJ; Nutting CM;
    Br J Radiol; 2009 Jul; 82(979):585-94. PubMed ID: 19332518
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Compensator-based intensity-modulated radiotherapy in head and neck cancer: our experience in achieving dosimetric parameters and their clinical correlation.
    Nangia S; Chufal KS; Arivazhagan V; Srinivas P; Tyagi A; Ghosh D
    Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):485-92. PubMed ID: 16909973
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy.
    Münter MW; Karger CP; Hoffner SG; Hof H; Thilmann C; Rudat V; Nill S; Wannenmacher M; Debus J
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):175-84. PubMed ID: 14697436
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Patterns of Recurrence in Electively Irradiated Lymph Node Regions After Definitive Accelerated Intensity Modulated Radiation Therapy for Head and Neck Squamous Cell Carcinoma.
    van den Bosch S; Dijkema T; Verhoef LC; Zwijnenburg EM; Janssens GO; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):766-74. PubMed ID: 26972649
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial.
    Gupta T; Agarwal J; Jain S; Phurailatpam R; Kannan S; Ghosh-Laskar S; Murthy V; Budrukkar A; Dinshaw K; Prabhash K; Chaturvedi P; D'Cruz A
    Radiother Oncol; 2012 Sep; 104(3):343-8. PubMed ID: 22853852
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dosimetric comparison of helical tomotherapy, intensity-modulated radiation therapy, volumetric-modulated arc therapy, and 3-dimensional conformal therapy for the treatment of T1N0 glottic cancer.
    Ekici K; Pepele EK; Yaprak B; Temelli O; Eraslan AF; Kucuk N; Altınok AY; Sut PA; Alpak OD; Colak C; Mayadagli A
    Med Dosim; 2016 Winter; 41(4):329-333. PubMed ID: 27765542
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Organ sparing and clinical outcome with step-and-shoot IMRT for head and neck cancer: a mono-institutional experience.
    Mazzola R; Ferrera G; Alongi F; Mannino M; Abbate B; Cucchiara T; Iacoviello G; Sciumè F; Di Paola G; Federico M; Blasi L; Lo Casto A; Lagalla R; Messana D
    Radiol Med; 2015 Aug; 120(8):753-8. PubMed ID: 25663551
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Multicriteria optimization enables less experienced planners to efficiently produce high quality treatment plans in head and neck cancer radiotherapy.
    Kierkels RG; Visser R; Bijl HP; Langendijk JA; van 't Veld AA; Steenbakkers RJ; Korevaar EW
    Radiat Oncol; 2015 Apr; 10():87. PubMed ID: 25885444
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hybaroxic radiotherapy of lesions of the oropharynx.
    Wildermuth O
    Nunt Radiol; 1968 Mar; 34(3):227-44. PubMed ID: 5717803
    [No Abstract]   [Full Text] [Related]  

  • 79. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
    Rosenthal DI; Chambers MS; Weber RS; Eisbruch A
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The potential benefit of swallowing sparing intensity modulated radiotherapy to reduce swallowing dysfunction: an in silico planning comparative study.
    van der Laan HP; Christianen ME; Bijl HP; Schilstra C; Langendijk JA
    Radiother Oncol; 2012 Apr; 103(1):76-81. PubMed ID: 22112778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.